The generic EpiPen is already causing some insurance companies to drop the real one

Https%3a%2f%2fblueprint-api-production.s3.amazonaws.com%2fuploads%2fcard%2fimage%2f346832%2f31ec506b-1128-458d-9433-e932b9809507

Feed-twFeed-fb

The introduction of a generic version of the life-saving — and expensive — EpiPen was heralded as a long overdue fix. But the move is now causing some insurance companies to change how they approach coverage of the allergy tool. 

The insurer Cigna on Thursday said the company would no longer cover the full-price EpiPen, which costs as much as $600. Those prices sparked outrage last summer when customers with high-deductible healthcare plans were caught off guard by the high prices for a once-reasonable healthcare need. The pharmaceutical company Mylan bought the rights to the EpiPen in 2007 and systematically raised the allergy tool’s prices over the following nine years.  Read more…

More about Cvs, Healthcare And Medicine, Mylan, Epipen, and Business
Source: Mashable

Leave a Reply